/Investor DB

DBL Partners — 2014 Investments

4 investments dated 2014 · listed companies and verified rows first · show all

SolexelinJul 2014SEC filingmedium confidence

EnergyMilpitas, US

Mehrdad Moslehi(Executive Officer, Director)inMarinus (Mark) Kerstens(Executive Officer)Michael Wingert(Executive Officer, Director)

BoardJan van Dokkum(Director)Reyad Fezzani(Director)

Board seatIra Ehrenpreis· per SEC Form D · $138.4M raise · filed Feb 2016

Co-investorsDag VenturesImperative Science VenturesKleiner Perkins

Farmers Business Networkfbn.comin𝕏Series A · Jun 2014 · $3.3M

Farmers Business Network (FBN) operates an agriculture marketplace where farmers buy inputs and supplies directly from manufacturers, access financing and grain marketing programs, and use data insights drawn from a network of over 100,000 member farms.

AgTechB2B MarketplacesFintechFoodTechSan Mateo, US

Amol Deshpande(Founder)inCharles Baron(Founder)inDiego Lopez Casanello(Executive Officer, Director)inGuillaume Luebke(Executive Officer)in

BoardLorenzo Gonzalez(Director)John Vaske(Executive Officer, Director)

Co-investors3Spoke CapitalAcre Venture PartnersBow CapitalColle Capital PartnersFuture Communities CapitalGV (Google Ventures)+5 more

The RealRealtherealreal.comin𝕏Apr 2014

The RealReal is an online marketplace for authenticated luxury consignment, allowing consumers to buy and sell pre-owned designer clothing, accessories, jewelry, watches, and home goods.

Circular EconomyConsumerE-commerceMarketplacesSan Francisco, US

Julie Wainwright(Founder)Matt Gustke(Executive Officer)inHenry V. Barry(Executive Officer)

BoardMathias Schilling(Director)inCynthia Ringo(Director)Keval Desai(Director)in

Co-investorsAcrew CapitalAspect VenturesBright Pixel CapitalCanaan PartnersExpansion Venture CapitalGreycroft+13 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Five Prime Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.